Liver Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance
Journal of Liver Cancer
;
: 25-31, 2020.
Artículo
| WPRIM
| ID: wpr-836095
ABSTRACT
Hepatocellular carcinoma (HCC) surveillance is recommended when the annual incidence of HCC exceeds 1.5%. In 2018, several international guidelines included alternative surveillance modalities, such as computed tomography and magnetic resonance imaging (MRI), as alternatives for patients with inadequate surveillance with an ultrasound. Currently, abbreviated MRI selectively includes several key sequences and is emerging as an effective tool for HCC surveillance with reduced cost and scan time and the required diagnostic performance. The incidence of HCC substantially impacts the benefits of surveillance in terms of cost-effectiveness. Therefore, we need to individualize imaging surveillance of HCC, tailor screening, and determine risk-stratified strategies. The purpose of this article was to present a brief overview of the diagnostic performance and cost-effectiveness of liver MRI as an HCC surveillance tool.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Guía de Práctica Clínica
/
Estudio de tamizaje
Revista:
Journal of Liver Cancer
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS